294 related articles for article (PubMed ID: 22610784)
1. Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats.
Nirogi R; Bhyrapuneni G; Kandikere V; Muddana N; Saralaya R; Komarneni P; Mudigonda K; Mukkanti K
Biopharm Drug Dispos; 2012 Jul; 33(5):265-77. PubMed ID: 22610784
[TBL] [Abstract][Full Text] [Related]
2. Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study.
Semvua HH; Mtabho CM; Fillekes Q; van den Boogaard J; Kisonga RM; Mleoh L; Ndaro A; Kisanga ER; van der Ven A; Aarnoutse RE; Kibiki GS; Boeree MJ; Burger DM
Antivir Ther; 2013; 18(1):105-13. PubMed ID: 23043067
[TBL] [Abstract][Full Text] [Related]
3. Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet.
Frampton JE; Croom KF
Drugs; 2006; 66(11):1501-12; discussion 1513-4. PubMed ID: 16906786
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.
Colbers AP; Hawkins DA; Gingelmaier A; Kabeya K; Rockstroh JK; Wyen C; Weizsäcker K; Sadiq ST; Ivanovic J; Giaquinto C; Taylor GP; Moltó J; Burger DM;
AIDS; 2013 Mar; 27(5):739-48. PubMed ID: 23169329
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir, emtricitabine intracellular and plasma, and efavirenz plasma concentration decay following drug intake cessation: implications for HIV treatment and prevention.
Jackson A; Moyle G; Watson V; Tjia J; Ammara A; Back D; Mohabeer M; Gazzard B; Boffito M
J Acquir Immune Defic Syndr; 2013 Mar; 62(3):275-81. PubMed ID: 23274933
[TBL] [Abstract][Full Text] [Related]
6. No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to Atripla.
Burger D; van Luin M; Bosch M; van der Ven A; Brouwer AM; Keuter M; Dofferhoff T; Koopmans PP
J Acquir Immune Defic Syndr; 2010 Aug; 54(5):e12-3. PubMed ID: 20647821
[No Abstract] [Full Text] [Related]
7. Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.
Dumond JB; Yeh RF; Patterson KB; Corbett AH; Jung BH; Rezk NL; Bridges AS; Stewart PW; Cohen MS; Kashuba AD
AIDS; 2007 Sep; 21(14):1899-907. PubMed ID: 17721097
[TBL] [Abstract][Full Text] [Related]
8. [Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1].
Oyagüez I; Casado MA; Cotarelo M; Ramírez-Arellano A; Mallolas J
Farm Hosp; 2009; 33(5):247-56. PubMed ID: 19775575
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry.
Nirogi R; Bhyrapuneni G; Kandikere V; Mudigonda K; Komarneni P; Aleti R; Mukkanti K
Biomed Chromatogr; 2009 Apr; 23(4):371-81. PubMed ID: 18937306
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and placental transfer of single-dose tenofovir 1% vaginal gel in term pregnancy.
Beigi R; Noguchi L; Parsons T; Macio I; Kunjara Na Ayudhya RP; Chen J; Hendrix CW; Mâsse B; Valentine M; Piper J; Watts DH
J Infect Dis; 2011 Nov; 204(10):1527-31. PubMed ID: 21930612
[TBL] [Abstract][Full Text] [Related]
11. Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery.
Gingelmaier A; Kurowski M; Kästner R; Eberle J; Mylonas I; Belohradsky BH; Friese K; Grubert TA
AIDS; 2006 Aug; 20(13):1737-43. PubMed ID: 16931938
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.
Hirt D; Urien S; Rey E; Arrivé E; Ekouévi DK; Coffié P; Leang SK; Lalsab S; Avit D; Nerrienet E; McIntyre J; Blanche S; Dabis F; Tréluyer JM
Antimicrob Agents Chemother; 2009 Mar; 53(3):1067-73. PubMed ID: 19104016
[TBL] [Abstract][Full Text] [Related]
13. Effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, an antiretroviral single-tablet regimen for the treatment of HIV infection.
Custodio JM; Yin X; Hepner M; Ling KH; Cheng A; Kearney BP; Ramanathan S
J Clin Pharmacol; 2014 Apr; 54(4):378-85. PubMed ID: 24142299
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of genistein and its conjugated metabolites in pregnant Sprague-Dawley rats following single and repeated genistein administration.
Soucy NV; Parkinson HD; Sochaski MA; Borghoff SJ
Toxicol Sci; 2006 Mar; 90(1):230-40. PubMed ID: 16352619
[TBL] [Abstract][Full Text] [Related]
15. Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.
Llibre JM; Clotet B
AIDS Rev; 2012; 14(3):168-78. PubMed ID: 22833060
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).
Else LJ; Taylor S; Back DJ; Khoo SH
Antivir Ther; 2011; 16(8):1139-47. PubMed ID: 22155898
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).
Hirt D; Urien S; Ekouévi DK; Rey E; Arrivé E; Blanche S; Amani-Bosse C; Nerrienet E; Gray G; Kone M; Leang SK; McIntyre J; Dabis F; Tréluyer JM;
Clin Pharmacol Ther; 2009 Feb; 85(2):182-9. PubMed ID: 18987623
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of zidovudine and lamivudine from rat tissues by liquid chromatography/tandem mass spectrometry.
Alnouti Y; Lewis SR; White CA; Bartlett MG
Rapid Commun Mass Spectrom; 2005; 19(4):503-8. PubMed ID: 15678520
[TBL] [Abstract][Full Text] [Related]
19. Effects of a protein-rich drink or a standard meal on the pharmacokinetics of elvitegravir, cobicistat, emtricitabine and tenofovir in healthy Japanese male subjects: a randomized, three-way crossover study.
Shiomi M; Matsuki S; Ikeda A; Ishikawa T; Nishino N; Kimura M; Irie S
J Clin Pharmacol; 2014 Jun; 54(6):640-8. PubMed ID: 24615728
[TBL] [Abstract][Full Text] [Related]
20. A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet.
King J; McCall M; Cannella A; Markiewicz MA; James A; Hood CB; Acosta EP
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):e130-2. PubMed ID: 22046602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
